$AUPH From the ER WEBCAST 5/10/2022. LUPKYNIS Prescription Start Forms (PSF) 1Q 2021 --------------257 1Q 2022 -----------------461 Year-to-date 2022 ----647 80% of PSFs are filled within 90 days, and 70% continue on Lupkynis 90 days. End of 1Q 2022 there were 461 PSFs. 1Q scripts filled, 0.8 X 461 = 368 patients on Lupkynis end of 1Q 2022. 70% continue 6 months. 0.7 X 368 = 257 patients continued Lupkynis 1Q 2022 to 2Q 2022. PG said there are currently 1071 patients on Lupkynis. 257 patients on Lupkynis 1Q 2022 continued on Lupkynis to 2Q 2022. 1071- 257 = 814 patients started taking Lupkynis during 2Q 2022. 368 patients 1Q2022 generated 21mn dollars revenue, 814 should generate around 26 mn dollars. [368/12 = 814/X, where X is expected 2Q 2022 revenue]. That does not include the rest of May 2022, and the entire month of June 2022. Looks like 2Q is going to be a blockbuster. [JMHO, not investing advice]
7
18
18 Likes